Wilms tumour

[1]  K. Pritchard-Jones,et al.  The clinical impact of observer variability in lung nodule classification in children with Wilms tumour , 2022, Pediatric blood & cancer.

[2]  M. Chintagumpala,et al.  Impact of the First Generation of Children's Oncology Group Clinical Trials on Clinical Practice for Wilms Tumor. , 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

[3]  C. Rübe,et al.  Fifty years of clinical and research studies for childhood renal tumors within the International Society of Pediatric Oncology (SIOP). , 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  C. Rübe,et al.  Prognostic Factors for Wilms Tumor Recurrence: A Review of the Literature , 2021, Cancers.

[5]  Y. Kaneko,et al.  Wilms tumour surveillance in at-risk children: Literature review and recommendations from the SIOP-Europe Host Genome Working Group and SIOP Renal Tumour Study Group. , 2021, European journal of cancer.

[6]  R. Williams,et al.  Comparative analysis of the clinical characteristics and outcomes of patients with Wilms tumor in the United Kingdom and Japan , 2021, Pediatric blood & cancer.

[7]  P. Ehrlich,et al.  Surgical Management of Wilms Tumor (Nephroblastoma) and Renal Cell Carcinoma in Children and Young Adults. , 2021, Surgical oncology clinics of North America.

[8]  S. Behjati,et al.  Maturation Block in Childhood Cancer. , 2021, Cancer discovery.

[9]  R. Kuiper,et al.  TRIM28 variants and Wilms' tumour predisposition , 2021, The Journal of pathology.

[10]  S. Behjati,et al.  Predisposition to cancer in children and adolescents. , 2021, The Lancet. Child & adolescent health.

[11]  S. Knapp,et al.  Drugging the “Undruggable” MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood Cancers , 2021, Cancer Research.

[12]  J. Aitken,et al.  Stage at diagnosis and survival by stage for the leading childhood cancers in three populations of sub‐Saharan Africa , 2021, International journal of cancer.

[13]  J. Dome,et al.  New approaches to risk stratification for Wilms tumor. , 2020, Current opinion in pediatrics.

[14]  B. Geoerger,et al.  Unmet needs for relapsed or refractory Wilms tumour: Mapping the molecular features, exploring organoids and designing early phase trials - A collaborative SIOP-RTSG, COG and ITCC session at the first SIOPE meeting. , 2020, European journal of cancer.

[15]  S. Furth,et al.  Kidney Outcomes and Hypertension in Survivors of Wilms Tumor: A Prospective Cohort Study. , 2020, The Journal of pediatrics.

[16]  A. Apple,et al.  Wilms Tumor in Sub-Saharan Africa: Molecular and Social Determinants of a Global Pediatric Health Disparity , 2020, Frontiers in Oncology.

[17]  C. Rübe,et al.  The SIOP-Renal Tumour Study Group consensus statement on flank target volume delineation for highly conformal radiotherapy. , 2020, The Lancet. Child & adolescent health.

[18]  K. Ness,et al.  Long‐term renal function after treatment for unilateral, nonsyndromic Wilms tumor. A report from the St. Jude Lifetime Cohort Study , 2020, Pediatric blood & cancer.

[19]  G. Chagaluka,et al.  Working Together to Build a Better Future for Children With Cancer in Africa , 2020, JCO global oncology.

[20]  S. D. de Souza,et al.  Assessment of somatic mutations in urine and plasma of Wilms tumor patients , 2020, Cancer medicine.

[21]  E. Steliarova-Foucher,et al.  Incidence of childhood renal tumours: An international population‐based study , 2020, International journal of cancer.

[22]  M. Chintagumpala,et al.  Results of Treatment for Patients With Multicentric or Bilaterally Predisposed Unilateral Wilms Tumor (AREN0534): A report from the Children's Oncology Group , 2020, Cancer.

[23]  Ninad Oak,et al.  Recent advances in Wilms tumor predisposition. , 2020, Human molecular genetics.

[24]  G. Chagaluka,et al.  Improvement of overall survival in the Collaborative Wilms Tumour Africa Project , 2020, Pediatric blood & cancer.

[25]  E. Papaemmanuil,et al.  11p15.5 epimutations in children with Wilms tumor and hepatoblastoma detected in peripheral blood , 2020, Cancer.

[26]  H. Brisse,et al.  From Wilms to kidney tumors: which ones require a biopsy? , 2020, Pediatric Radiology.

[27]  D. Rodeberg,et al.  Minimally invasive surgery for pediatric renal tumors: A systematic review by the APSA Cancer Committee. , 2020, Journal of pediatric surgery.

[28]  J. Sandberg,et al.  Imaging Characteristics of Nephrogenic Rests Versus Small Wilms Tumors: A Report From the Children's Oncology Group Study AREN03B2. , 2020, AJR. American journal of roentgenology.

[29]  P. Kemmeren,et al.  An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity , 2020, Nature Communications.

[30]  James R. Anderson,et al.  Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children's Oncology Group AREN0321 Study. , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  G. Vujanić,et al.  Renal Tumors of Childhood—A Histopathologic Pattern-Based Diagnostic Approach , 2020, Cancers.

[32]  H. Correa,et al.  Health disparities among Tennessee pediatric renal tumor patients. , 2020, Journal of pediatric surgery.

[33]  Kayla L. Stratton,et al.  Late mortality and chronic health conditions in long-term survivors of early-adolescent and young adult cancers: a retrospective cohort analysis from the Childhood Cancer Survivor Study. , 2020, The Lancet. Oncology.

[34]  H. Brisse,et al.  Outcome of patients with stage IV high-risk Wilms tumour treated according to the SIOP2001 protocol: A report of the SIOP Renal Tumour Study Group. , 2020, European journal of cancer.

[35]  Guía Familiar,et al.  Children's Oncology Group , 2020, Definitions.

[36]  K. Pritchard-Jones,et al.  The role of imaging in the initial investigation of paediatric renal tumours. , 2020, The Lancet. Child & adolescent health.

[37]  G. Nason,et al.  A systematic review of genitourinary injuries arising from rugby and football. , 2020, Journal of pediatric urology.

[38]  C. Rübe,et al.  Is radiotherapy required in first‐line treatment of stage I diffuse anaplastic Wilms tumor? A report of SIOP‐RTSG, AIEOP, JWiTS, and UKCCSG , 2019, Pediatric blood & cancer.

[39]  Matthew D. Young,et al.  Embryonal precursors of Wilms tumor , 2019, Science.

[40]  M. Chintagumpala,et al.  Global Disparities in Wilms Tumor. , 2019, The Journal of surgical research.

[41]  Heather L. Mulder,et al.  Forty-five patient-derived xenografts capture the clinical and biological heterogeneity of Wilms tumor , 2019, Nature Communications.

[42]  Chuan He,et al.  Progress toward liquid biopsies in pediatric solid tumors , 2019, Cancer and Metastasis Reviews.

[43]  A. Millar,et al.  Surgery for the complex Wilms tumour , 2019, Pediatric Surgery International.

[44]  J. Vandesompele,et al.  Minimally invasive classification of paediatric solid tumours using reduced representation bisulphite sequencing of cell-free DNA: a proof-of-principle study , 2020, Epigenetics.

[45]  M. Gessler,et al.  High-risk blastemal Wilms tumor can be modeled by 3D spheroid cultures in vitro , 2019, Oncogene.

[46]  F. Locatelli,et al.  High dose chemotherapy and autologous hematopoietic cell transplantation for Wilms tumor: a study of the European Society for Blood and Marrow Transplantation , 2019, Bone Marrow Transplantation.

[47]  James R. Anderson,et al.  Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study Report. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  R. Williams,et al.  The diagnostic accuracy and clinical utility of pediatric renal tumor biopsy: Report of the UK experience in the SIOP UK WT 2001 trial , 2019, Pediatric blood & cancer.

[49]  S. Seal,et al.  Identification of new Wilms tumour predisposition genes: an exome sequencing study , 2019, The Lancet. Child & adolescent health.

[50]  R. Atun,et al.  Estimating the total incidence of global childhood cancer: a simulation-based analysis. , 2019, The Lancet. Oncology.

[51]  K. Pritchard-Jones,et al.  Science and health for all children with cancer , 2019, Science.

[52]  A. Toutain,et al.  Overgrowth syndromes — clinical and molecular aspects and tumour risk , 2019, Nature Reviews Endocrinology.

[53]  T. Margaritis,et al.  Tubuloids derived from human adult kidney and urine for personalized disease modeling , 2019, Nature Biotechnology.

[54]  B. Dawson,et al.  Tegavivint and the β-catenin/ALDH Axis in Chemotherapy-Resistant and Metastatic Osteosarcoma. , 2019, Journal of the National Cancer Institute.

[55]  M. Gessler,et al.  TRIM28 haploinsufficiency predisposes to Wilms tumor , 2019, International journal of cancer.

[56]  S. Behjati,et al.  The genetic changes of Wilms tumour , 2019, Nature Reviews Nephrology.

[57]  M. Gessler,et al.  Loss or oncogenic mutation of DROSHA impairs kidney development and function, but is not sufficient for Wilms tumor formation , 2018, International journal of cancer.

[58]  O. Delattre,et al.  Circulating tumor DNA analysis enables molecular characterization of pediatric renal tumors at diagnosis , 2018, International journal of cancer.

[59]  James R. Anderson,et al.  Impact of cyclophosphamide and etoposide on outcome of clear cell sarcoma of the kidney treated on the National Wilms Tumor Study‐5 (NWTS‐5) , 2018, Pediatric blood & cancer.

[60]  J. Dome,et al.  Outcome of Wilms tumor patients with bone metastasis enrolled on National Wilms Tumor Studies 1‐5: A report from the Children's Oncology Group , 2018, Pediatric blood & cancer.

[61]  M. Coleman,et al.  Childhood cancer burden: a review of global estimates. , 2019, The Lancet. Oncology.

[62]  I. Helenowski,et al.  Cardiac-Sparing Whole Lung Intensity Modulated Radiation Therapy in Children With Wilms Tumor: Final Report on Technique and Abdominal Field Matching to Maximize Normal Tissue Protection. , 2019, Practical radiation oncology.

[63]  C. Clark,et al.  An alternative approach to contrast-enhanced imaging: diffusion-weighted imaging and T1-weighted imaging identifies and quantifies necrosis in Wilms tumour , 2018, European Radiology.

[64]  D. Gerhard,et al.  A unique subset of low-risk Wilms tumors is characterized by loss of function of TRIM28 (KAP1), a gene critical in early renal development: A Children’s Oncology Group study , 2018, PloS one.

[65]  P. Ehrlich,et al.  Technical Considerations for Nephron-Sparing Surgery in Children: What Is Needed to Preserve Renal Units? , 2018, The Journal of surgical research.

[66]  G. Rivard,et al.  Management of acquired von Willebrand syndrome. , 2018, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[67]  James R. Anderson,et al.  Impact of Surveillance Imaging Modality on Survival After Recurrence in Patients With Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[68]  M. Gessler,et al.  The UMBRELLA SIOP–RTSG 2016 Wilms tumour pathology and molecular biology protocol , 2018, Nature Reviews Urology.

[69]  A. Attarbaschi,et al.  Outcome of two patients with bilateral nephroblastomatosis/Wilms tumour treated with an add-on 13-cis retinoic acid therapy – Case report , 2018, Pediatric hematology and oncology.

[70]  A. Davidoff,et al.  Bilateral Wilms Tumor: A Surgical Perspective , 2018, Children.

[71]  S. Fosså,et al.  Fertility Among Female Survivors of Childhood, Adolescent, and Young Adult Cancer: Protocol for Two Pan-European Studies (PanCareLIFE) , 2018, JMIR research protocols.

[72]  George D. Cresswell,et al.  Somatic TP53 Mutations Are Detectable in Circulating Tumor DNA from Children with Anaplastic Wilms Tumors , 2018, Translational oncology.

[73]  Sarah A. Teichmann,et al.  Single-cell transcriptomes from human kidneys reveal the cellular identity of renal tumors , 2018, Science.

[74]  C. Bodkyn,et al.  Baseline characteristics and outcomes of children with cancer in the English‐speaking Caribbean: A multinational retrospective cohort , 2018, Pediatric blood & cancer.

[75]  A. Zauber,et al.  Health supervision for people with Bloom syndrome , 2018, American journal of medical genetics. Part A.

[76]  K. Pritchard-Jones,et al.  Relapse of Wilms' tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group-International Society of Paediatric Oncology Wilms' tumour protocol database. , 2018, The Lancet. Oncology.

[77]  R. Hammer,et al.  Loss of Dis3l2 partially phenocopies Perlman syndrome in mice and results in up-regulation of Igf2 in nephron progenitor cells , 2018, Genes & development.

[78]  M. Hudson,et al.  Reproductive Function and Outcomes in Female Survivors of Childhood, Adolescent, and Young Adult Cancer: A Review. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[79]  A. Reeve,et al.  Germline mutations and somatic inactivation of TRIM28 in Wilms tumour , 2018, PLoS genetics.

[80]  G. Chagaluka,et al.  Improved outcome at end of treatment in the collaborative Wilms tumour Africa project , 2018, Pediatric blood & cancer.

[81]  H. Clevers,et al.  Organoids in cancer research , 2018, Nature Reviews Cancer.

[82]  James R. Anderson,et al.  Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 Study. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[83]  R. Hennekam,et al.  Expert consensus document: Clinical and molecular diagnosis, screening and management of Beckwith–Wiedemann syndrome: an international consensus statement , 2018, Nature Reviews Endocrinology.

[84]  James R. Anderson,et al.  Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[85]  C. Rübe,et al.  Position paper: Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP–RTSG 2016 protocol , 2017, Nature Reviews Urology.

[86]  S. Luna-Fineman,et al.  Effects of malnutrition on treatment‐related morbidity and survival of children with cancer in Nicaragua , 2017, Pediatric blood & cancer.

[87]  K. Pritchard-Jones,et al.  Paediatrics: Integrating genomics to dig deeper into Wilms tumour biology , 2017, Nature Reviews Urology.

[88]  M. Chintagumpala,et al.  Results of the First Prospective Multi-institutional Treatment Study in Children With Bilateral Wilms Tumor (AREN0534): A Report From the Children's Oncology Group , 2017, Annals of surgery.

[89]  Qing-Rong Chen,et al.  A Children's Oncology Group and TARGET Initiative Exploring the Genetic Landscape of Wilms Tumor , 2017, Nature Genetics.

[90]  M. Gessler,et al.  TP53 alterations in Wilms tumour represent progression events with strong intratumour heterogeneity that are closely linked but not limited to anaplasia , 2017, The journal of pathology. Clinical research.

[91]  K. Pritchard-Jones,et al.  Bilateral Wilms tumour: a review of clinical and molecular features , 2017, Expert Reviews in Molecular Medicine.

[92]  Michael W. Bishop,et al.  Premature Ovarian Insufficiency in Childhood Cancer Survivors: A Report From the St. Jude Lifetime Cohort , 2017, The Journal of clinical endocrinology and metabolism.

[93]  R. Comstock,et al.  Epidemiology of Chest, Rib, Thoracic Spine, and Abdomen Injuries Among United States High School Athletes, 2005/06 to 2013/14 , 2017, Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine.

[94]  K. Pritchard-Jones,et al.  Review of phase I and II trials for Wilms' tumour - Can we optimise the search for novel agents? , 2017, European journal of cancer.

[95]  P. Nikkels,et al.  Apparent diffusion coefficient as it relates to histopathology findings in post-chemotherapy nephroblastoma: a feasibility study , 2017, Pediatric Radiology.

[96]  Eva Steliarova-Foucher,et al.  International incidence of childhood cancer, 2001–10: a population-based registry study , 2017, The Lancet. Oncology.

[97]  S. Seal,et al.  Biallelic TRIP13 mutations predispose to Wilms tumor and chromosome missegregation , 2017, Nature Genetics.

[98]  H. Jalanko,et al.  Renal findings in patients with Mulibrey nanism , 2017, Pediatric Nephrology.

[99]  N. Sebire,et al.  Nephrogenic rests in Wilms tumors treated with preoperative chemotherapy: The UK SIOP Wilms Tumor 2001 Trial experience , 2017, Pediatric blood & cancer.

[100]  James R. Anderson,et al.  Clinical Outcome and Biological Predictors of Relapse After Nephrectomy Only for Very Low-risk Wilms Tumor: A Report From Children's Oncology Group AREN0532 , 2017, Annals of surgery.

[101]  D. Papagiannopoulos,et al.  Revisiting Sports Precautions in Children With Solitary Kidneys and Congenital Anomalies of the Kidney and Urinary Tract. , 2017, Urology.

[102]  M. Ortega,et al.  An Analysis of Treatment Failure in Wilms Tumor (WT): A Report from the Central American Association of Pediatric Hematology/Oncology (AHOPCA) , 2016 .

[103]  Liliana Vásquez,et al.  Factors associated with the latency to diagnosis of childhood cancer in Peru , 2016, Pediatric blood & cancer.

[104]  A. Naranjo,et al.  Surgical protocol violations in children with renal tumors provides an opportunity to improve pediatric cancer care: a report from the Children's Oncology Group , 2016, Pediatric blood & cancer.

[105]  Kathy Pritchard-Jones,et al.  Biology and treatment of renal tumours in childhood. , 2016, European journal of cancer.

[106]  Richard A. Moore,et al.  Significance of TP53 Mutation in Wilms Tumors with Diffuse Anaplasia: A Report from the Children's Oncology Group , 2016, Clinical Cancer Research.

[107]  James R. Anderson,et al.  Association of Chromosome 1q Gain With Inferior Survival in Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[108]  J. Carey,et al.  Wilms tumor and trisomy 18: Is there an association? , 2016, American journal of medical genetics. Part C, Seminars in medical genetics.

[109]  M. O'sullivan,et al.  Gain of 1q As a Prognostic Biomarker in Wilms Tumors (WTs) Treated With Preoperative Chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 Trial: A SIOP Renal Tumours Biology Consortium Study , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[110]  George D. Cresswell,et al.  Intra-Tumor Genetic Heterogeneity in Wilms Tumor: Clonal Evolution and Clinical Implications , 2016, EBioMedicine.

[111]  M. Gessler,et al.  Mutually exclusive BCOR internal tandem duplications and YWHAE‐NUTM2 fusions in clear cell sarcoma of kidney: not the full story , 2016, The Journal of pathology.

[112]  W. Foulkes,et al.  Evolution of Renal Cysts to Anaplastic Sarcoma of Kidney in a Child With DICER1 Syndrome , 2016, Pediatric blood & cancer.

[113]  A. McMahon.  Development of the Mammalian Kidney. , 2016, Current topics in developmental biology.

[114]  K. Pritchard-Jones,et al.  Omission of doxorubicin from the treatment of stage II–III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial , 2015, The Lancet.

[115]  K. Pritchard-Jones,et al.  Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[116]  K. Pritchard-Jones,et al.  Paediatrics: Long-term effects of Wilms tumour therapy on renal function , 2015, Nature Reviews Urology.

[117]  D. Srivastava,et al.  Renal function in survivors of nonsyndromic Wilms tumor treated with unilateral radical nephrectomy , 2015, Cancer.

[118]  R. Goldsby,et al.  Second malignant neoplasms among children, adolescents and young adults with Wilms tumor , 2015, Pediatric blood & cancer.

[119]  M. Fukuzawa,et al.  Consistent in-frame internal tandem duplications of BCOR characterize clear cell sarcoma of the kidney , 2015, Nature Genetics.

[120]  K. Pritchard-Jones,et al.  Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG). , 2015, European journal of cancer.

[121]  Y. Arai,et al.  A high incidence of WT1 abnormality in bilateral Wilms tumours in Japan, and the penetrance rates in children with WT1 germline mutation , 2015, British Journal of Cancer.

[122]  Eckart Meese,et al.  Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors. , 2015, Cancer cell.

[123]  Richard A. Moore,et al.  Recurrent DGCR8, DROSHA, and SIX homeodomain mutations in favorable histology Wilms tumors. , 2015, Cancer cell.

[124]  M. Shrubsole,et al.  Risk factors for abandonment of Wilms tumor therapy in Kenya , 2015, Pediatric blood & cancer.

[125]  D. Gisselsson,et al.  Multiple mechanisms of MYCN dysregulation in Wilms tumour , 2015, Oncotarget.

[126]  T. Eden,et al.  The Collaborative Wilms Tumour Africa Project; baseline evaluation of Wilms tumour treatment and outcome in eight institutes in sub-Saharan Africa. , 2015, European journal of cancer.

[127]  D. Green,et al.  Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG). , 2015, European journal of cancer.

[128]  N. Graf,et al.  Current Concepts in Surgery for Wilms Tumor—The Risk and Function-Adapted Strategy , 2014, European Journal of Pediatric Surgery.

[129]  Jianbo Sun,et al.  Eya1 interacts with Six2 and Myc to regulate expansion of the nephron progenitor pool during nephrogenesis. , 2014, Developmental cell.

[130]  James R. Anderson,et al.  TP53 Mutational Status Is a Potential Marker for Risk Stratification in Wilms Tumour with Diffuse Anaplasia , 2014, PloS one.

[131]  Dinesh Rakheja,et al.  Somatic mutations in DROSHA and DICER1 impair microRNA biogenesis through distinct mechanisms in Wilms tumours , 2014, Nature Communications.

[132]  P. Radice,et al.  The IGF signalling pathway in Wilms tumours - A report from the ENCCA Renal Tumours Biology-driven drug development workshop , 2014, Oncotarget.

[133]  S. Seal,et al.  Germline mutations in the PAF1 complex gene CTR9 predispose to Wilms tumour , 2014, Nature Communications.

[134]  P. Grundy,et al.  Recurrent somatic mutation in DROSHA induces microRNA profile changes in Wilms tumour , 2014, Nature Communications.

[135]  J. Dome,et al.  Risk stratification for wilms tumor: current approach and future directions. , 2014, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

[136]  Hao Zhu,et al.  Lin28 sustains early renal progenitors and induces Wilms tumor , 2014, Genes & development.

[137]  K. Pritchard-Jones,et al.  Why should survivors of childhood renal tumor and others with only one kidney be denied the chance to play contact sports? , 2014, Expert review of anticancer therapy.

[138]  N. Breslow,et al.  Outcome of patients with stage II/favorable histology wilms tumor with and without local tumor spill: A report from the National Wilms Tumor Study Group , 2014, Pediatric blood & cancer.

[139]  Silvia Rossi,et al.  Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5--a population-based study. , 2014, The Lancet. Oncology.

[140]  P. Radice,et al.  Is Wilms Tumor a Candidate Neoplasia for Treatment with WNT/β-Catenin Pathway Modulators?—A Report from the Renal Tumors Biology-Driven Drug Development Workshop , 2013, Molecular Cancer Therapeutics.

[141]  K. Pritchard-Jones,et al.  Incidence and outcomes of patients with late recurrence of Wilms' tumor , 2013, Pediatric blood & cancer.

[142]  T. Eden,et al.  Clinical trials to improve childhood cancer care and survival in sub-Saharan Africa , 2013, Nature Reviews Clinical Oncology.

[143]  K. Pritchard-Jones,et al.  Treatment of Wilms tumor in low-income countries: challenges and potential solutions. , 2013, Future oncology.

[144]  James R. Anderson,et al.  Children's Oncology Group's 2013 blueprint for research: Renal tumors , 2013, Pediatric blood & cancer.

[145]  A. Naranjo,et al.  Detection of preoperative wilms tumor rupture with CT: a report from the Children's Oncology Group. , 2013, Radiology.

[146]  K. Pritchard-Jones,et al.  SIOP PODC: Clinical guidelines for the management of children with Wilms tumour in a low income setting , 2013, Pediatric blood & cancer.

[147]  D. Machin,et al.  An international strategy to determine the role of high dose therapy in recurrent Wilms' tumour. , 2013, European journal of cancer.

[148]  A. Naranjo,et al.  Primary nephrectomy and intraoperative tumor spill: report from the Children's Oncology Group (COG) renal tumors committee. , 2013, Journal of pediatric surgery.

[149]  D. Green.  The evolution of treatment for Wilms tumor. , 2013, Journal of pediatric surgery.

[150]  G. Chagaluka,et al.  Management of Children With a Wilms Tumor in Malawi, Sub-Saharan Africa , 2012, Journal of pediatric hematology/oncology.

[151]  H. van Tinteren,et al.  Treatment of pulmonary metastases in children with stage IV nephroblastoma with risk-based use of pulmonary radiotherapy. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[152]  H. Caron,et al.  The efficacy and toxicity of SIOP preoperative chemotherapy in Malawian children with a Wilms tumour , 2012, Pediatric blood & cancer.

[153]  K. Pritchard-Jones,et al.  The contribution of chest CT-scan at diagnosis in children with unilateral Wilms' tumour. Results of the SIOP 2001 study. , 2012, European journal of cancer.

[154]  M. Molyneux,et al.  Practical issues in relation to clinical trials in children in low-income countries: experience from the front line , 2012, Archives of Disease in Childhood.

[155]  N. Breslow,et al.  Treatments and outcomes for end-stage renal disease following Wilms tumor , 2012, Pediatric Nephrology.

[156]  Nazneen Rahman,et al.  Stratification of Wilms tumor by genetic and epigenetic analysis , 2012, Oncotarget.

[157]  J. Opitz,et al.  Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibility , 2012, Nature Genetics.

[158]  Maria Grazia Valsecchi,et al.  Nutritional status at diagnosis is related to clinical outcomes in children and adolescents with cancer: a perspective from Central America. , 2012, European journal of cancer.

[159]  G. Armstrong,et al.  Twenty‐five year follow‐up of childhood Wilms tumor: A report from the Childhood Cancer Survivor Study , 2011, Pediatric blood & cancer.

[160]  M. Gessler,et al.  Retinoic acid pathway activity in wilms tumors and characterization of biological responses in vitro , 2011, Molecular Cancer.

[161]  G. Levitt.  Renal tumours: long-term outcome , 2011, Pediatric Nephrology.

[162]  N. Breslow,et al.  Risk factors for end stage renal disease in non-WT1-syndromic Wilms tumor. , 2011, The Journal of urology.

[163]  M. Rivera,et al.  The WTX tumor suppressor regulates mesenchymal progenitor cell fate specification. , 2011, Developmental cell.

[164]  V. Huff,et al.  Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene , 2011, Nature Reviews Cancer.

[165]  Fei Gao,et al.  Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation. , 2011, The Journal of clinical investigation.

[166]  H. Heij,et al.  Challenges and outcome of Wilms' tumour management in a resource-constrained setting. , 2010, African journal of paediatric surgery : AJPS.

[167]  A. Boddy,et al.  Malnourished Malawian patients presenting with large Wilms tumours have a decreased vincristine clearance rate. , 2010, European journal of cancer.

[168]  James R. Anderson,et al.  Outcomes of children with favorable histology wilms tumor and peritoneal implants treated in National Wilms Tumor Studies-4 and -5. , 2010, International journal of radiation oncology, biology, physics.

[169]  M. Gessler,et al.  Subtype-Specific FBXW7 Mutation and MYCN Copy Number Gain in Wilms' Tumor , 2010, Clinical Cancer Research.

[170]  N. Breslow,et al.  Intraoperative spillage of favorable histology wilms tumor cells: influence of irradiation and chemotherapy regimens on abdominal recurrence. A report from the National Wilms Tumor Study Group. , 2010, International journal of radiation oncology, biology, physics.

[171]  L. Strong,et al.  Wt 1 ablation and Igf 2 upregulation in mice result in Wilms tumors with elevated ERK 1 / 2 phosphorylation , 2010 .

[172]  H. Caron,et al.  Acute malnutrition is common in Malawian patients with a Wilms tumour: A role for peanut butter , 2009, Pediatric blood & cancer.

[173]  M. Gessler,et al.  WTX inactivation is a frequent, but late event in Wilms tumors without apparent clinical impact , 2009, Genes, chromosomes & cancer.

[174]  J. Dome,et al.  Treatment of relapsed Wilms tumors: lessons learned , 2009, Expert review of anticancer therapy.

[175]  Gretchen M. Williams,et al.  DICER1 Mutations in Familial Pleuropulmonary Blastoma , 2009, Science.

[176]  H. Jalanko,et al.  High frequency of tumours in Mulibrey nanism , 2009, The Journal of pathology.

[177]  N. Breslow,et al.  Early and late mortality after diagnosis of wilms tumor. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[178]  A. Ashworth,et al.  Perilobar Nephrogenic Rests Are Nonobligate Molecular Genetic Precursor Lesions of Insulin-Like Growth Factor-II-Associated Wilms Tumors , 2008, Clinical Cancer Research.

[179]  P. Ehrlich,et al.  Ureteral extension in Wilms' tumor: a report from the National Wilms' Tumor Study Group (NWTSG). , 2008, Journal of pediatric surgery.

[180]  R. Arora,et al.  Wilms tumour in Sudan , 2008, Pediatric blood & cancer.

[181]  N. Breslow,et al.  Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group , 2008, Pediatric blood & cancer.

[182]  S. G. Rice.  Medical Conditions Affecting Sports Participation , 1994, Pediatrics.

[183]  K. Matthay,et al.  A phase 2 trial of all‐trans‐retinoic acid in combination with interferon‐α2a in children with recurrent neuroblastoma or Wilms tumor: A Pediatric Oncology Branch, NCI and Children's Oncology Group Study , 2007 .

[184]  N. Breslow,et al.  Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: A report from the National Wilms Tumor Study Group , 2007, Pediatric blood & cancer.

[185]  C. Mathew,et al.  Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer , 2007, Nature Genetics.

[186]  A. Reeve,et al.  Sequential WT1 and CTNNB1 mutations and alterations of β-catenin localisation in intralobar nephrogenic rests and associated Wilms tumours: two case studies , 2006, Journal of Clinical Pathology.

[187]  P. Babyn,et al.  Wilms tumour: prognostic factors, staging, therapy and late effects , 2007, Pediatric Radiology.

[188]  N. Rahman,et al.  Surveillance for Wilms tumour in at-risk children: pragmatic recommendations for best practice , 2006, Archives of Disease in Childhood.

[189]  Kevin C Oeffinger,et al.  Chronic health conditions in adult survivors of childhood cancer. , 2006, The New England journal of medicine.

[190]  Eva Steliarova-Foucher,et al.  Malignant renal tumours incidence and survival in European children (1978-1997): report from the Automated Childhood Cancer Information System project. , 2006, European journal of cancer.

[191]  N. Breslow,et al.  Age distributions, birth weights, nephrogenic rests, and heterogeneity in the pathogenesis of Wilms tumor , 2006, Pediatric blood & cancer.

[192]  N. Breslow,et al.  Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[193]  N. Rahman,et al.  Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour , 2006, Journal of Medical Genetics.

[194]  N. Breslow,et al.  End stage renal disease in patients with Wilms tumor: results from the National Wilms Tumor Study Group and the United States Renal Data System. , 2005, The Journal of urology.

[195]  N. Breslow,et al.  Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[196]  Bernard V Fischbach,et al.  WAGR Syndrome: A Clinical Review of 54 Cases , 2005, Pediatrics.

[197]  E. Perlman.  Pediatric Renal Tumors: Practical Updates for the Pathologist , 2005, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[198]  R. Hennekam,et al.  High incidence of malformation syndromes in a series of 1,073 children with cancer , 2005, American journal of medical genetics. Part A.

[199]  S. Seal,et al.  Biallelic BRCA2 mutations are associated with multiple malignancies in childhood including familial Wilms tumour , 2005, Journal of Medical Genetics.

[200]  D. Green,et al.  The treatment of stages I-IV favorable histology Wilms' tumor. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[201]  N. Breslow,et al.  Epigenetic differences between Wilms' tumours in white and east-Asian children , 2004, The Lancet.

[202]  N. Breslow,et al.  Characteristics and outcomes of children with the Wilms tumor-Aniridia syndrome: a report from the National Wilms Tumor Study Group. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[203]  Dieter Harms,et al.  Revised International Society of Paediatric Oncology (SIOP) working classification of renal tumors of childhood. , 2002, Medical and pediatric oncology.

[204]  K. Yokomori,et al.  Cancer-prone syndrome of mosaic variegated aneuploidy and total premature chromatid separation: report of five infants. , 2001, American journal of medical genetics.

[205]  N. Breslow,et al.  Treatment with nephrectomy only for small, stage I/favorable histology Wilms' tumor: a report from the National Wilms' Tumor Study Group. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[206]  J. Varley,et al.  Relative frequency and morphology of cancers in carriers of germline TP53 mutations , 2001, Oncogene.

[207]  N. Breslow,et al.  Intravascular Extension of Wilms Tumor , 2001, Annals of surgery.

[208]  N. Breslow,et al.  Congestive heart failure after treatment for Wilms' tumor: a report from the National Wilms' Tumor Study group. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[209]  R. Potter,et al.  Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[210]  N Graf,et al.  THE ROLE OF PREOPERATIVE CHEMOTHERAPY IN THE MANAGEMENT OF WILMS' TUMOR: The SIOP Studies , 2000 .

[211]  M. von Knebel Doeberitz,et al.  Mutational activation of the beta-catenin proto-oncogene is a common event in the development of Wilms' tumors. , 1999, Cancer research.

[212]  J. Roganovic,et al.  Epidemiology of childhood cancer. , 1999, IARC scientific publications.

[213]  P Scambler,et al.  Frasier syndrome is caused by defective alternative splicing of WT1 leading to an altered ratio of WT1 +/-KTS splice isoforms. , 1998, Human molecular genetics.

[214]  N E Breslow,et al.  Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: a report from the National Wilms' Tumor Study Group. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[215]  Marc Fellous,et al.  Donor splice-site mutations in WT1 are responsible for Frasier syndrome , 1997, Nature Genetics.

[216]  S. Schneider,et al.  Correlation of germ-line mutations and two-hit inactivation of the WT1 gene with Wilms tumors of stromal-predominant histology. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[217]  N. Breslow,et al.  Focal versus diffuse anaplasia in Wilms tumor--new definitions with prognostic significance: a report from the National Wilms Tumor Study Group. , 1996, The American journal of surgical pathology.

[218]  S. Chew,et al.  Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31. , 1995, American journal of human genetics.

[219]  E. Franco,et al.  A randomized clinical trial of single‐dose versus fractionated‐dose dactinomycin in the treatment of wilms' tumor. Results after extended follow‐up , 1994 .

[220]  R. Mueller.  The Denys-Drash syndrome. , 1994, Journal of medical genetics.

[221]  O. Ishida,et al.  Familial primary hyperparathyroidism complicated with Wilms' tumor. , 1994, Internal medicine.

[222]  P. Voûte,et al.  Results of the Sixth International Society of Pediatric Oncology Wilms' Tumor Trial and Study: a risk-adapted therapeutic approach in Wilms' tumor. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[223]  D. Housman,et al.  Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome , 1991, Cell.

[224]  D. Parkin,et al.  International variations in the incidence of childhood renal tumours. , 1990, British Journal of Cancer.

[225]  P. Voûte,et al.  Wilm's tumor with pulmonary metastases at diagnosis: the significance of primary chemotherapy. International Society of Pediatric Oncology Nephroblastoma Trial and Study Committee. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[226]  A. Poustka,et al.  Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping , 1990, Nature.

[227]  D. Housman,et al.  Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus , 1990, Cell.

[228]  N. Kiviat,et al.  Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor. , 1990, Pediatric pathology.

[229]  E. Beckwith,et al.  Histopathology and prognosis of Wilms tumor Results from the first national wilms' tumor study , 1978, Cancer.

[230]  A. Meadows,et al.  Patterns of second malignant neoplasms in children , 1977, Cancer.

[231]  D. Hays.  Preoperative versus postoperative radiotherapy, single versus multiple courses of actinomycin D, in the treatment of Wilms' Tumor—Preliminary results of a controlled clinical trial conduced the internatinal society of pediatric oncology (S.I.O.P.) , 1977 .

[232]  P. Voûte,et al.  Preoperative versus postoperative radiotherapy, single versus multiple courses of actinomycin d, in the treatment of Wilms' tumor. Preliminary results of a controlled clinical trial conducted by the international society of paediatric oncology (S.I.O.P.) , 1976, Cancer.

[233]  H. Bartsch,et al.  International Agency for Research on Cancer. , 1969, WHO chronicle.

[234]  James R. Anderson,et al.  Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor : A Report From the Children ' s Oncology Group Study AREN 0532 , 2022 .